Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| CANbridge Pharmaceuticals | 2025 | Post Ipo Equity | $12.7M | Beijing |
| WAM Bio | 2025 | Seed | $1.5M | Dover |
| Minghui Pharmaceutical | 2025 | Series Unknown | $131.0M | Shanghai |
| Tongxuan Medical | 2025 | Series B | $41.8M | Cheng |
| LTZ Therapeutics | 2025 | Corporate Round | Undisclosed | San Francisco |
| Atantares | 2025 | Series A | $8.6M | Jingan |
| Simaixu Biotechnology | 2025 | Series Unknown | $1.6M | Suzhou |
| Auron Therapeutics | 2025 | Series Unknown | Undisclosed | Newton |
| Sharpa | 2025 | Series A | $100.0M | Singapore |
| TigerGraph | 2025 | Series Unknown | Undisclosed | Redwood City |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | CANbridge Pharmaceuticals | Post Ipo Equity | $12.7M | Beijing, China |
| 102 | WAM Bio | Seed | $1.5M | Dover, United States |
| 103 | Minghui Pharmaceutical | Series Unknown | $131.0M | Shanghai, China |
| 104 | Tongxuan Medical | Series B | $41.8M | Cheng, China |
| 105 | LTZ Therapeutics | Corporate Round | Undisclosed | San Francisco, United States |
| 106 | Atantares | Series A | $8.6M | Jingan, China |
| 107 | Simaixu Biotechnology | Series Unknown | $1.6M | Suzhou, China |
| 108 | Auron Therapeutics | Series Unknown | Undisclosed | Newton, United States |
| 109 | Sharpa | Series A | $100.0M | Singapore, Singapore |
| 110 | TigerGraph | Series Unknown | Undisclosed | Redwood City, United States |
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.
Tongxuan Medical is a platform for balloon interventional device research and development.
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Atantares is a company that makes smart chips that empower medical technology.
Simaixu Biotechnology is a biopharmaceutical firm that develop small molecule drugs for cancer, and chronic diseases with new technologies
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Sharpa is a robotics company that develops robots and core robotic components for real-world deployment of robotic applications.
TigerGraph supports advanced analytics and machine learning platforms through its distributed native graph database.
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
TARS is a company that integrates embodied intelligence.
Sesame Therapeutics is a healthcare company that provides precision oncology medicines with therapeutic windows.
Z.ai is an AI company that develops foundational AI models and tools that support language, voice, and multimedia tasks.
Biren Technology is an AI chip startup that develops intelligent processors for GPU and DSA computation architectures.
Qianshou is a dating application that helps to find the right partner for life by using artificial matchmaker service.
Tianchen Biotechnology is a biotech company that specializes in the development and sales of ophthalmology-related medical products.
LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
Jiangling Technology provides high-quality optical measurement and inspection equipment to semiconductor customers around the world.
Yuanbao is a preferred Internet insurance platform.
Yuyao Bio is an innovative drug research and development company.
Axera is a hight-tech semiconductor company focused on developing world class Artificial intelligence (AI) SoCs for computer applications.
Pratilipi is a language storytelling platform that brings readers, writers, and their stories together.
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Weimei Health is a provider of smart solutions for medical information technology
Qiming Venture Partners has invested in 370 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Biotechnology, Medical, Artificial Intelligence (AI), Health Care, Therapeutics. The firm invests across 35 different industry categories.
Among tracked funding rounds, Biren Technology received $209.3M in a Series Unknown round. Qiming Venture Partners's total known invested capital is $11.0B.
Qiming Venture Partners's average investment size is $54.4M across its portfolio of 370 companies.
Recent Qiming Venture Partners portfolio additions include CANbridge Pharmaceuticals, WAM Bio, Minghui Pharmaceutical, Tongxuan Medical, LTZ Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors